Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Proteome Sciences Appoints New CEO As Annual Loss Narrows

18th May 2016 08:24

LONDON (Alliance News) - Proteome Sciences PLC on Wednesday appointed a new chief executive and posted a narrowed pretax loss for 2015 thanks to lower costs.

Proteome, which makes technology to map and analyse protein changes, said Jeremy Haigh will become chief executive in June. Haigh is currently the chairman of Cogent Skills Ltd, the UK strategic body for skills in the science industry, and a member of the Imperial College Health Partners Advisory Council.

The company said it had decided to expand its executive team, led by Executive Chairman Christopher Peace, with a "senior figure strongly connected to the pharmaceutical industry".

The appointment came as Proteome said its pretax loss for the year to the end of December narrowed to GBP3.3 million from GBP4.2 million a year earlier. Revenue grew to GBP1.9 million from GBP1.6 million and this was complemented by a decline in administrative costs to GBP4.2 million from GBP4.9 million.

Proteome said licence, sales and services revenue grew 30% in the year, with 51% growth from its biomarker services. The company said its facilities are currently running at full capacity and it is on track to deliver a significant increase in revenue in 2016.

Proteome shares were down 1.7% to 19.66 pence.

By Sam Unsted; [email protected]; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.


Related Shares:

Proteome
FTSE 100 Latest
Value8,809.74
Change53.53